Latest Articles

Publication Date
Ginsenoside Rg3 antagonises endometriosis glycolysis via the tripartite motif containing 28 and pyruvate dehydrogenase kinase 4 signalling pathway.

Endometriosis is a common gynaecological disorder characterised by the ectopic growth of endometrial-like tissue, which can lead to clinical symptoms such as chronic inflammation, pelvic pain, and infertility. Aberrant cellular …

Published: Jan. 7, 2026, midnight
Japan sees rising endometrial, cervical cancer rates among young women - 毎日新聞

Japan sees rising endometrial, cervical cancer rates among young women 毎日新聞

Published: Jan. 6, 2026, 7:53 a.m.
NHS app to fast-track prostate cancer diagnoses - coastfm.co.uk

NHS app to fast-track prostate cancer diagnoses coastfm.co.uk

Published: Jan. 6, 2026, 3 a.m.
[Features of myocardial infarction in women].

Myocardial infarction is a major public health concern for women. Hospitalization rates are increasing, particularly among young women. This trend is probably linked to the growing prevalence of cardiovascular risk …

Published: Jan. 6, 2026, midnight
Using Lenvatinib/Pembrolizumab for Endometrial Cancer in Clinical Practice - Targeted Oncology

Using Lenvatinib/Pembrolizumab for Endometrial Cancer in Clinical Practice Targeted Oncology

Published: Jan. 5, 2026, 1:27 p.m.
Real-World Results for Lenvatinib Plus Pembrolizumab in Endometrial Cancer - Targeted Oncology

Real-World Results for Lenvatinib Plus Pembrolizumab in Endometrial Cancer Targeted Oncology

Published: Jan. 5, 2026, 1:12 p.m.
Lenvatinib Plus Pembrolizumab in Endometrial Cancer After Neoadjuvant/Adjuvant Therapy - Targeted Oncology

Lenvatinib Plus Pembrolizumab in Endometrial Cancer After Neoadjuvant/Adjuvant Therapy Targeted Oncology

Published: Jan. 5, 2026, 1:07 p.m.
Does menopause increase endometrial cancer risk? | Tap to know more | Inshorts - Inshorts

Does menopause increase endometrial cancer risk? | Tap to know more | Inshorts Inshorts

Published: Jan. 4, 2026, 7:43 a.m.
FBXW7 Identified as Key Regulator of M2 Macrophage Polarization in Endometrial Cancer - geneonline.com

FBXW7 Identified as Key Regulator of M2 Macrophage Polarization in Endometrial Cancer geneonline.com

Published: Jan. 4, 2026, 6:37 a.m.
FBXW7 Modulates M2 Macrophage Polarization in Endometrial Cancer - Bioengineer.org

FBXW7 Modulates M2 Macrophage Polarization in Endometrial Cancer Bioengineer.org

Published: Jan. 4, 2026, 5:52 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!